News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,338 Results
Type
Article (14139)
Company Profile (282)
Press Release (250917)
Section
Business (79472)
Career Advice (153)
Deals (13221)
Drug Delivery (35)
Drug Development (50416)
Employer Resources (31)
FDA (5710)
Job Trends (5127)
News (144328)
Policy (10027)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (907)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21616)
ALS (54)
Alzheimer's disease (807)
Antibody-drug conjugate (ADC) (79)
Approvals (5714)
Artificial intelligence (100)
Autoimmune disease (7)
Automation (5)
Bankruptcy (102)
Best Places to Work (4560)
BIOSECURE Act (5)
Biosimilars (35)
Biotechnology (232)
Bladder cancer (40)
Brain cancer (19)
Breast cancer (132)
Cancer (1176)
Cardiovascular disease (93)
Career advice (132)
Career pathing (2)
CAR-T (101)
Cell therapy (291)
Cervical cancer (5)
Clinical research (40671)
Collaboration (462)
Compensation (196)
Complete response letters (13)
COVID-19 (1029)
CRISPR (33)
C-suite (129)
Cystic fibrosis (75)
Data (1212)
Denatured (11)
Depression (27)
Diabetes (112)
Diagnostics (1283)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (74)
Drug pricing (27)
Drug shortages (3)
Duchenne muscular dystrophy (64)
Earnings (29389)
Editorial (16)
Employer branding (4)
Employer resources (29)
Events (47888)
Executive appointments (377)
FDA (6264)
Featured Employer (34)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (432)
Gene editing (80)
Generative AI (9)
Gene therapy (211)
GLP-1 (342)
Government (1074)
Grass and pollen (2)
Guidances (17)
Healthcare (6585)
Huntington's disease (21)
IgA nephropathy (18)
Immunology and inflammation (71)
Indications (16)
Infectious disease (1084)
Inflammatory bowel disease (109)
Inflation Reduction Act (8)
Influenza (16)
Intellectual property (51)
Interviews (17)
IPO (7255)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (198)
Leadership (2)
Legal (1385)
Liver cancer (30)
Lung cancer (168)
Lymphoma (77)
Machine learning (1)
Management (7)
Manufacturing (107)
MASH (46)
Medical device (2584)
Medtech (2585)
Mergers & acquisitions (6219)
Metabolic disorders (336)
Multiple sclerosis (46)
NASH (13)
Neurodegenerative disease (53)
Neuropsychiatric disorders (22)
Neuroscience (1144)
NextGen: Class of 2025 (2014)
Non-profit (852)
Northern California (1415)
Now hiring (21)
Obesity (174)
Opinion (99)
Ovarian cancer (50)
Pain (38)
Pancreatic cancer (48)
Parkinson's disease (94)
Partnered (6)
Patents (98)
Patient recruitment (56)
Peanut (35)
People (25415)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14356)
Phase II (18922)
Phase III (11956)
Pipeline (575)
Podcasts (42)
Policy (33)
Postmarket research (852)
Preclinical (6014)
Press Release (30)
Prostate cancer (49)
Psychedelics (35)
Radiopharmaceuticals (210)
Rare diseases (263)
Real estate (1414)
Recruiting (12)
Regulatory (8498)
Reports (14)
Research institute (935)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (52)
Series A (85)
Series B (51)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1256)
Special edition (10)
Sponsored (11)
Startups (1969)
State (1)
Stomach cancer (4)
Supply chain (17)
The Weekly (31)
United States (11196)
Vaccines (195)
Venture capitalists (27)
Webinars (7)
Weight loss (98)
Women's health (14)
Worklife (2)
Date
Today (3)
Last 7 days (398)
Last 30 days (1561)
Last 365 days (20178)
2025 (3513)
2024 (20552)
2023 (22414)
2022 (26822)
2021 (27806)
2020 (23356)
2019 (16223)
2018 (11739)
2017 (13745)
2016 (11839)
2015 (14350)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (37)
Alaska (2)
Arizona (50)
Arkansas (5)
Asia (17142)
Australia (2902)
California (3231)
Canada (997)
China (290)
Colorado (125)
Connecticut (136)
Delaware (78)
Europe (36870)
Florida (376)
Georgia (95)
Idaho (16)
Illinois (200)
India (6)
Indiana (79)
Iowa (1)
Japan (63)
Kansas (58)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (424)
Massachusetts (2564)
Michigan (68)
Minnesota (124)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (14)
New Hampshire (13)
New Jersey (811)
New Mexico (11)
New York (890)
North Carolina (497)
North Dakota (4)
Northern California (1415)
Ohio (102)
Oklahoma (8)
Oregon (21)
Pennsylvania (608)
Puerto Rico (1)
Rhode Island (13)
South America (207)
South Carolina (3)
Southern California (1256)
Tennessee (24)
Texas (365)
Utah (45)
Virginia (65)
Washington D.C. (27)
Washington State (302)
Wisconsin (13)
265,338 Results for "lacerta therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Lacerta Therapeutics Expands Executive Leadership Team
Lacerta Therapeutics announces an expansion in the executive leadership team: Kenneth Warrington, Jr., PhD, co-founder of Lacerta, has joined as the company’s Chief Technology Officer, and Darin Falk, PhD, former Vice President of Gene Therapy Programs at Lacerta, will now serve as the company’s Chief Scientific Officer.
March 1, 2022
·
3 min read
Business
Concept Companies Leads Development Efforts on Second Phase for Lacerta Therapeutics in Alachua’s Progress District
Concept Companies, a national commercial real estate developer specializing in turnkey projects, announces the commencement of the design and construction of a new 11,961-square-foot laboratory facility for Lacerta Therapeutics, Inc., a gene therapy company.
May 27, 2022
·
3 min read
BioMidwest
Lacerta and Prevail, A Wholly Owned Subsidiary of Lilly, Sign Agreement to Develop Novel AAV Capsids for CNS Disorders
Lacerta Therapeutics, a leader in the development of adeno-associated virus technologies for the treatment of central nervous system diseases, announced a new AAV capsid licensing and research collaboration agreement with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company.
August 23, 2022
·
2 min read
BioMidwest
GrowFL Announces Lacerta Therapeutics as an Honoree: 11th Annual Florida Companies to Watch
Lacerta Therapeutics is pleased to be among the top 50 second-stage companies in Florida selected as an 11th Annual GrowFL Florida Companies to Watch honoree, a statewide competition that identifies companies expected to see significant growth over the next several years.
February 16, 2022
·
3 min read
Business
Lacerta Therapeutics Appoints Min Wang, PhD, JD and Marc Wolff to its Board of Directors
Lacerta Therapeutics, Inc. a gene therapy company dedicated to the discovery and development of AAV-based gene therapies, appoints Min Wang, PhD, JD and Marc Wolff to its Board of Directors.
November 24, 2021
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Layoffs
Repare Therapeutics to Cut Staff Again, This Time by 75%
The latest Repare Therapeutics layoffs will include its chief medical officer and could leave the biotech with fewer than 35 employees as it works to advance two Phase I clinical programs.
February 25, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Allogene Therapeutics Announces Participation in March Investor Conference
February 26, 2025
·
2 min read
Business
Concept Companies Breaks Ground on New Location for Lacerta Therapeutics in Alachua’s Copeland Park
Concept Companies, a Gainesville headquartered full-service real estate development and construction firm, has announced commencement of construction on a new office and lab building in Copeland Park for Lacerta Therapeutics, a clinical-stage gene therapy company.
October 9, 2019
·
2 min read
Press Releases
Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast
March 5, 2025
·
1 min read
1 of 26,534
Next
